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Abstract
The CBP histone acetyltransferase plays important roles in development and disease by acting as a transcriptional coregulator. A small
reduction in the amount of Drosophila CBP (dCBP) leads to a specific loss of signaling by the TGF- molecules Dpp and Screw in the early
embryo. We show that the expression of Screw itself, and that of two regulators of Dpp/Screw activity, Twisted-gastrulation and the Tolloid
protease, is compromised in dCBP mutant embryos. This prevents Dpp/Screw from initiating a signal transduction event in the receiving cell. Smad
proteins, the intracellular transducers of the signal, fail to become activated by phosphorylation in dCBP mutants, leading to diminished
Dpp/Screw-target gene expression. At a slightly later stage of development, Dpp/Screw-signaling recovers in dCBP mutants, but without a
restoration of Dpp/Screw-target gene expression. In this situation, dCBP acts downstream of Smad protein phosphorylation, presumably via direct
interactions with the Drosophila Smad protein Mad. It appears that a major function of dCBP in the embryo is to regulate upstream components
of the Dpp/Screw pathway by Smad-independent mechanisms, as well as acting as a Smad coactivator on downstream target genes. These results
highlight the exceptional sensitivity of components in the TGF- signaling pathway to a decline in CBP concentration.
© 2003 Elsevier Inc. All rights reserved.
Introduction
Transcriptional coregulators have recently been found to
contribute important roles to transcription factor function, and
thereby to play decisive roles in cell-differentiation during
development (reviewed by Mannervik et al., 1999). Coregula-
tors are recruited to cis-regulatory regions through interactions
with DNA-binding proteins. The coactivator CBP (CREB-
binding protein) is equipped with intrinsic histone acetyltrans-
ferase (HAT) activity and directly interacts with sequence-
specific DNA-binding proteins to mediate their transactivation
capability through histone acetylation and/or interaction with a
RNA polymerase complex (reviewed in Chan and La
Thangue, 2001). In addition, CBP has the ability to acetylate
nonhistone proteins, such as the p53 tumor suppressor and
some of the basal transcription factors. The central position of
CBP in transcriptional regulation is reflected by its important
roles in development and disease (reviewed in Goodman and
Smolik, 2000). Although CBP has been shown to interact with
a plethora of mammalian transcription factors, including
CREB, nuclear hormone receptors, and Smad proteins, in vivo
evidence that supports the biological significance of these in-
teractions is scarce. The Drosophila embryo constitutes an
excellent model for making connections between abnormal
development and changes in gene expression. We have taken
a genetic approach to identify which transcription factor–CBP
interactions are important in vivo, using the early Drosophila
embryo.
Mutations in the Drosophila CBP ortholog, nejire (nej or
dCBP), cause multiple developmental defects, including im-
pairment of Hedgehog and Wingless signaling, as well as
defects in dorsal–ventral patterning (Goodman and Smolik,
2000). In dorsal–ventral patterning, dCBP has been suggested
to act as a coactivator for both the Dorsal transcription factor,
and for the Smad protein Mad, which transduces the TGF-
signal Decapentaplegic (Dpp) (Akimaru et al., 1997b; Waltzer
and Bienz, 1999). Dorsal initiates dorsal–ventral patterning by
forming a concentration gradient in the ventral half of the
embryo, where it can act as an activator or repressor, depend-
ing on DNA context (reviewed in Mannervik et al., 1999). One
gene that is repressed by Dorsal encodes the TGF- signaling
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molecule Dpp (Huang et al., 1993). Dpp protein production is
in this way confined to the dorsal part of the embryo, from
where it is secreted and diffuses toward the ventral side to form
an activity gradient that subdivides the dorsal ectoderm (re-
viewed in Podos and Ferguson, 1999). This gradient is formed
with the help of several other extracellular proteins. An inhib-
itor of Dpp activity, Short gastrulation (Sog), is produced in
lateral parts of the embryo where it is believed to act as a sink
for the Dpp protein (Francois et al., 1994). Interestingly, the
Sog protein acts as an inhibitor in lateral cells, but is able to
potentiate the Dpp signal far away from its source of synthesis,
resulting in peak Dpp activity in dorsal-most cells (Ashe and
Levine, 1999). Twisted gastrulation (Tsg) collaborates with
Sog protein in antagonizing Dpp activity (Chang et al., 2001;
Ross et al., 2001; Scott et al., 2001). It is believed that Tsg
makes Sog a better substrate for the Tolloid protease, which
cleaves the Sog inhibitor to activate the Dpp ligand (Marques
et al., 1997). Differentiation of dorsal-most cells also requires
another TGF- molecule, Screw (Arora et al., 1994). Dpp and
Screw proteins bind to serine/threonine kinase receptors
(Thick-veins, Saxophone, and Punt), which leads to phosphor-
ylation of the intracellular transducer of the signal, the Smad
protein Mad (reviewed in Podos and Ferguson, 1999). Upon
phosphorylation, Mad heterodimerizes with another Smad pro-
tein, Medea, and translocates to the nucleus where it binds to
DNA and activates Dpp target genes (reviewed in Raftery and
Sutherland, 1999).
In the early Drosophila embryo, dCBP mRNA is mater-
nally contributed. Removal of dCBP from the embryo there-
fore requires creation of chimeric flies with clones of homozy-
gous germ cells. Oocyte development is blocked in germ cells
homozygous for the strong dCBP allele nej3 (Akimaru et al.,
1997a). However, in the hypomorphic nej1 allele, homozygous
eggs and embryos are produced, but the reduction in dCBP
levels results in patterning defects (Akimaru et al., 1997b). It
has previously been observed that expression of Dpp/Screw-
target genes is compromised in dCBP mutant germline clone
embryos, leading to the hypothesis that dCBP acts as a Mad
Fig. 1. Expression of dCBP in dCBP mutant embryos. dCBP mRNA and
protein expression levels were determined in wild-type (wt) and dCBP
mutant (nej1) embryos derived from nej1 germline clones. Embryos are
oriented with anterior to the left and dorsal up. (A, B) Cellularizing wt and
mutant (nej1) embryos were hybridized with a digoxigenin-labeled anti-
sense dCBP RNA probe. dCBP mRNA is present ubiquitously due to its
maternal contribution. Slightly diminished dCBP mRNA amounts is found
in mutant (B) compared with wt (A) embryos. (C–E) Cellularized wt
embryos were stained with an antibody directed against the N terminus of
the dCBP protein. Staining is predominantly nuclear. In (C), the antibody
was left untreated, whereas in (D), it was preincubated with a GST-dCBP
fusion protein, resulting in almost complete absence of staining. By con-
trast, when the antibody was preincubated with GST protein (E), no
reduction in staining intensity occurred. (F, G) Transgenic embryos over-
expressing dCBP in central parts by use of the Kru¨ppel enhancer (Kr-CBP),
stained with the dCBP antibody. In a wt background (F), strong nuclear
staining is observed in all cells, which is further enhanced in the central
Kru¨ppel domain. In CBP mutant embryos (G), a small reduction in nuclear
staining was observed, except in the Kru¨ppel domain, where staining
remained strong. In fact, dCBP overexpression was more pronounced and
detected at an earlier stage in dCBP mutants due to diminished endogenous
dCBP levels (not shown).
Fig. 2. dpp, sog, and tsg expression in dCBP mutants. Embryos were
hybridized with digoxigenin-labeled antisense RNA probes. CBP mutant
embryos were derived from nej1 germline clones. (A, B) Wild-type (wt)
and mutant (nej1) embryos undergoing cellularization oriented with dorsal
up and anterior to the left were hybridized with a dpp probe. The mutant
embryo exhibits an essentially normal dpp expression pattern. (C, D)
Cellularizing embryos hybridized with a short-gastrulation (sog) probe are
shown from a ventrolateral view. The sog pattern consists of two lateral
stripes and is essentially normal in the CBP mutant. (E, F) Cellularized
embryos were stained with a twisted-gastrulation (tsg) probe and are
oriented with anterior to the left and dorsal up. The wild-type expression
pattern consists of an anterior cap and a patch of dorsal cells in the middle
of the embryo (E). In the dCBP mutant embryo shown in (F), expression
of the anterior cap is abolished and the dorsal staining does not extend as
far to the anterior as in wild-type.
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coactivator (Ashe et al., 2000; Waltzer and Bienz, 1999). Here,
we present results that raise the possibility that Dpp/Screw-
target genes instead fail to be expressed in dCBP mutants
because Dpp/Screw is unable to signal. We show that expres-
sion of two upstream regulators of Dpp/Screw activity, tsg and
tolloid, as well as screw itself, is reduced in dCBP mutants. As
a result, Mad is not phosphorylated in cells that would nor-
mally receive the Dpp/Screw signal. However, we also present
evidence suggesting that, at a slightly later stage of develop-
ment, dCBP acts downstream of Dpp/Screw-signaling as a
Mad coactivator.
Materials and methods
Fly strains and germline clones
Three dCBP alleles were used in this study; nejire1 (nej1)
and nej3 are excision lines derived from a P-element located
347 base pairs upstream of the second exon in the dCBP
gene (Akimaru et al., 1997a). nej3 deletes 2-3 kb of DNA
near the 5 end of the gene, and is believed to be a null allele
(Akimaru et al., 1997a), whereas nej1 is a hypomorph (Aki-
maru et al., 1997b). nejQ7 was isolated in an EMS screen for
modifiers of Deformed function, and is a stronger allele than
nej3 and therefore considered an antimorph (Florence and
McGinnis, 1998). dCBP mutant embryos derived from
germline clones were generated by the FLP-FRT method
(Chou and Perrimon, 1996). nej1 FRT/FM7c females were
crossed to ovoD FRT/Y; hs-FLP males. Progeny from this
cross were heatshocked at 37°C for 3 h on days 3, 4, and 5
after egglaying. nej1 FRT/ovoD FRT females were crossed
to wild-type males, to males containing the tolloid-lacZ
transgene (kindly provided by C. Rushlow), or to males
carrying a FM7 ftz-lacZ marked balancer chromosome, and
embryos collected on apple juice plates. OregonR or yw flies
were used as wild-type controls.
P-element construction and transformation
The dCBP cDNA was cloned as an AscI fragment into a
modified 22FPE vector (Kosman and Small, 1997) in which
the two copies of the even-skipped stripe 2 enhancer have
been replaced by two copies of the Kru¨ppel enhancer (de-
scribed in Stathopoulos et al., 2002, kindly provided by H.
Ashe). The enhancer is followed by the even-skipped basal
promoter and leader, an FRT-transcription stop signal-FRT
Fig. 3. Expression of the tolloid and screw genes requires dCBP. Wild-type
and CBP mutant embryos derived from nej1 germline clones were hybrid-
ized with digoxigenin-labeled probes. (A, B) Cellularizing wildtype (wt)
and mutant embryos oriented with anterior to the left and dorsal up
hybridized with a tolloid (tld) probe. Expression of tld is abolished in the
CBP mutant embryo, except for a small patch at the anterior (B). (C, D)
Dorsal view of a wt and mutant embryo at late cellularization/early gas-
trulation hybridized with the tld probe. In the wt embryo, tld expression is
repressed in the dorsal-most cells by Dpp signaling (arrowheads in C). Tld
expression partially recovers in CBP mutants at this stage, but fails to be
repressed along the dorsal midline (D, arrowheads). (E, F) Embryos con-
taining a tld-lacZ transgene are orientated with dorsal up and anterior to the
left and were hybridized with a digoxigenin-labeled lacZ antisense probe.
(E) Expression of the tld-lacZ transgene in wt embryos recapitulates the
endogenous tld pattern. In the CBP mutant embryo, no lacZ expression can
be detected (F). (G, H) Syncytial blastoderm embryos oriented with dorsal
up and anterior to the left after staining with a screw (scw) probe. Scw
expression is ubiquitous in both embryos, but the expression level is
reduced in the CBP mutant embryo (H) as compared with wt (G).
Fig. 4. TGF- signaling is prevented in dCBP mutant embryos. Embryos
were stained with an anti-phospho Smad antibody that detects signaling
from the TGF- molecules Dpp and Screw, or with an anti-Mad antibody.
They are oriented with dorsal up and anterior to the left. (A) In wild-type
(wt) cellularizing embryos, the Dpp/Screw signal is received in dorsal cells
as revealed by the antibody. (B) In the CBP mutant embryo undergoing
cellularization, Dpp/Screw signaling is prevented, except in the anterior-
most cells, as is evident from the absence of phospo-Smad staining. The
embryos shown in (C) and (D) are undergoing the early, rapid phase of
germband elongation. In both wt (C) and mutant (D) embryos, phospho-
Smad staining is observed, suggesting that Dpp/Screw signaling recovers
in CBP mutant embryos of this stage. Cellularizing wt (E) and CBP mutant
(F) embryos were stained with a Mad antibody. Staining is slightly reduced
in CBP mutant embryos. The mutant embryos in (B), (D), and (F) were
derived from nej1 germline clones.
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sequence, and the AscI site. The construct was injected
into yw flies following standard procedures (Rubin and
Spradling, 1982). The resulting transgenic flies were
crossed to 2-tubulin-FLP-containing males in order to re-
combine away the transcriptional stop signal and activate
expression of dCBP (Kosman and Small, 1997). Male prog-
eny in whose spermatocytes recombination had occurred
were crossed to wild-type or nej1 germline clone females
and embryos collected as described above.
Generation of dCBP antibody
Amino acids 1–174 of dCBP were amplified by PCR and
cloned into the pGEX 5X-1 vector to generate a GST-dCBP
fusion protein, which was expressed in bacterial BL21 cells
and purified on glutathione–sepharose beads. The fusion
protein was injected into guinea pigs (performed by Euro-
gentec, Belgium), and the serum was passed over a GST
column to remove GST reactive antibodies.
In situ hybridization and immunohistochemistry
RNA in situ hybridization using digoxigenin-labeled an-
tisense RNA probes was performed as previously described
(Jiang et al., 1991; Tautz and Pfeifle, 1989). Immunohisto-
chemistry was performed essentially as described previ-
ously (Manoukian and Krause, 1992). Embryos were fixed
in 4% formaldehyde and devitellinized in methanol. They
were then rehydrated and incubated in PBTH buffer (1
PBS, 0.1% Tween 20, 250 g/ml tRNA, and 50 g/ml
Heparin) for 1 h. The guinea pig anti-dCBP polyclonal
antibody (1:1000 dilution) or a rabbit anti-phospho Smad
polyclonal antibody (kindly provided by C.-H. Heldin,
1:2000 dilution) or a goat anti-Mad polyclonal antibody
(Santa Cruz Biotechnology, 1:50 dilution) was added and
incubated at 4°C overnight. Embryos were washed in PBTH
and the primary antibody detected using the Vectastain
ABC Elite kit. In Fig. 1D and E, the dCBP antibody was
blocked by preincubation with 10 g GST-dCBP or GST
protein at a 1:10 dilution in PBTH at room temperature for
3 h, followed by further dilution of the antibody to a final
dilution of 1:1000 prior to adding to embryos. For double
labeling, embryos were first subject to immunohistochem-
istry as described above, except that RNase inhibitor was
included in the PBTH buffer and then stained with the
rhomboid anti-sense RNA probe.
Results
A small reduction of dCBP levels in dCBP mutant
germline clone embryos
Patterning defects have previously been observed in
germline clone embryos from the nej1 allele of dCBP (Aki-
maru et al., 1997b), but the amount of dCBP present in such
embryos has not been previously determined. We therefore
examined dCBP mRNA and protein expression in dCBP
mutant embryos (Fig. 1). In both wild-type (Fig. 1A) and
dCBP mutant (Fig. 1B) embryos, dCBP mRNA is present
ubiquitously due to its maternal contribution. A small, but
reproducible, reduction in dCBP mRNA expression was
observed. In order to determine whether a similar change in
dCBP protein expression occurs in these embryos, an anti-
body was raised against the N-terminal part of the protein.
Fig. 1C shows a wild-type embryo stained with this anti-
body. Predominantly, nuclear staining was observed. Prein-
cubation of the antibody with a GST-dCBP fusion protein
(Fig. 1D), but not with GST protein (Fig. 1E), blocked
staining of wild-type embryos, indicating that the antibody
is specific for dCBP. Embryos overexpressing dCBP in a
central domain by control of the Kru¨ppel enhancer were
generated and stained with the antibody. Stronger staining
was observed in the Kru¨ppel domain than in the rest of the
embryo, demonstrating that the antibody recognizes dCBP
(Fig. 1F). When dCBP mutant embryos containing the
Kru¨ppel-dCBP transgene were stained with the antibody, a
reduction in the amount of endogenous dCBP was found,
while expression in the Kru¨ppel domain remained compa-
rable to that found in the wild-type (Fig. 1G). These results
demonstrate that dCBP protein is still present in dCBP
mutant embryos, but at a reduced level. The small reduction
of dCBP in these embryos allows us to find genes that are
especially sensitive to a decline in dCBP amounts, and for
whose expression dCBP may be particularly important.
Expression of dpp, sog, and tsg in dCBP mutant embryos
It has previously been shown that expression of Dpp-
target genes, such as Race, hindsight, U-shaped, and rhom-
boid, is diminished in embryos derived from dCBP germ-
line clones (Ashe et al., 2000; Waltzer and Bienz, 1999).
We have investigated what other genes are affected in the
early embryo by the reduction in dCBP levels. In particular,
we examined dCBP germline clone embryos for the expres-
sion of genes involved in generating active Dpp and Screw
protein, to see if dCBP is acting directly or indirectly on
Dpp/Screw-target genes.
We first examined the expression of dpp itself, the Dpp
inhibitor sog, as well as the Sog partner tsg. The dpp gene
is expressed in dorsal parts of the embryo. It is activated by
an unknown transcription factor and repressed by Dorsal in
ventral cells (Fig. 2A) (Huang et al., 1993). In dCBP mutant
embryos, dpp is expressed in a normal pattern (Fig. 2B).
The sog gene is expressed in two ventrolateral stripes in
response to the lowest threshold of Dorsal activity (Mark-
stein et al., 2002) (Fig. 2C). It is repressed in ventral parts,
presumably by the Snail protein. In dCBP mutant embryos,
sog is expressed to a normal extent (Fig. 2D). From these
results, we conclude that the unknown activator of dpp
expression and the Dorsal protein are unaffected by the
reduction in dCBP levels.
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Tsg cooperates with Sog protein in antagonizing Dpp
signaling (Ross et al., 2001). Its expression is restricted to
dorsal cells in the middle of the embryo and to an anterior
cap (Fig. 2E) (Mason et al., 1994). Expression of the ante-
rior cap is reduced in dCBP mutant embryos, and the mid-
dorsal domain is narrower than in wild-type embryos (Fig.
2F). This result suggests that one or more transcriptional
activators of tsg expression depend on dCBP for their ac-
tivity. It is possible that reduced tsg expression in dCBP
mutants affects the ability of Dpp/Screw to signal. How-
ever, unlike dCBP mutant embryos (Ashe et al., 2000; see
also Fig. 4), expression of the Dpp/Screw-target gene rhom-
boid expands in twisted gastrulation mutants (Ross et al.,
2001). Therefore, diminished tsg expression cannot account
for the dCBP mutant phenotype.
Tolloid and screw gene expression require dCBP
The Tolloid protease is necessary for generating active
Dpp and Screw protein by cleaving the Sog inhibitor. Like
dpp, tolloid is expressed on the dorsal side of cellularizing
Drosophila embryos (Shimell et al., 1991) (Fig. 3A). This
pattern is driven by a 800-bp enhancer, to which an un-
known, presumably ubiquitous, transcriptional activator
binds. Binding of the Dorsal protein together with cofactors
to this enhancer results in repression in the ventral half of
the embryo (Kirov et al., 1994). As can be seen in Fig. 3B,
the early expression pattern of the tolloid gene is almost
completely eliminated in embryos derived from dCBP
germline clones. Loss of the early tolloid expression pattern
in dCBP mutant embryos indicates that the unidentified
protein that activates tolloid transcription uses dCBP as a
coactivator. Moreover, it suggests that dCBP has a role in
the Dpp/Screw pathway that is independent of Smad pro-
teins, since the early tolloid pattern is unaffected by changes
in Dpp signaling (data not shown). The result also indicates
that dpp and tolloid expression are activated by different
proteins, with only the tolloid activator being dependent on
dCBP for its activity.
At a slightly later stage of development, during late
cellularization/early gastrulation, tolloid expression refines
into a different pattern. As shown in the dorsal view of the
wild-type embryo in Fig. 3C, tolloid expression becomes
restricted to stripes along the anterior–posterior axis, with
absence of staining in dorsal-most cells. This repression of
tolloid expression along the dorsal midline is due to Dpp/
Screw signaling. In dCBP mutant embryos, tolloid expres-
sion partly recovers at this later stage of development, and
additionally, fails to be repressed in dorsal midline cells
(Fig. 3D).
The activity of the isolated 800-bp tolloid enhancer cou-
pled to a lacZ reporter gene was examined in dCBP mutant
embryos. As shown previously, the tolloid enhancer reca-
pitulates the early tolloid pattern when introduced into wild-
type embryos (Kirov et al., 1994) (Fig. 3E). However,
expression of the tolloid-lacZ gene is eliminated in dCBP
mutant embryos; demonstrating that dCBP is regulating
transcription driven by the tolloid enhancer (Fig. 3F).
In addition to Dpp, specification of dorsal-most cell fates
requires a second TGF- molecule, Screw (Arora et al.,
1994). Although screw is expressed uniformly in the early
embryo (Arora et al., 1994) (Fig. 3G), its activity is re-
stricted to the dorsal side. In dCBP mutant embryos, screw
expression is reduced as compared with wild-type embryos
(Fig. 3H). As dorsal cell fate is sensitive to reductions in the
levels of Screw protein (Arora et al., 1994), diminished
screw expression may well contribute to a reduction of
Dpp/Screw-target gene expression in dCBP mutant em-
bryos. We have also examined the expression of Brinker, a
transcriptional repressor involved in Dpp signaling (Affolter
et al., 2001). No deviation from its normal pattern of ex-
pression could be detected in dCBP mutant embryos (data
not shown).
In summary, our results have established that transcrip-
tional activators regulating expression of the tsg, tolloid,
and screw genes depend on dCBP for their full activity. It
appears that the tolloid activator is most sensitive to the
reduction in dCBP levels. These data raise the possibility
that Dpp/Screw signaling is inhibited in dCBP mutants by
too little Tolloid and Screw protein.
TGF- signaling is impaired in early dCBP mutant
embryos
Reduced tolloid and screw expression might inhibit Dpp/
Screw signaling, which could explain the previously noted
lack of downstream target gene expression. To address this
issue, we used an antibody that specifically recognizes phos-
phorylated Smad proteins (Persson et al., 1998). Since
Smads are phosphorylated only in response to signaling by
TGF- molecules, this antibody can be used to measure the
activity of Dpp/Screw (Tanimoto et al., 2000). As previ-
ously shown, the anti-phospho Smad antibody stains the
dorsal-most region of wild-type embryos, where Dpp/Screw
signaling occurs (Dorfman and Shilo, 2001; Ross et al.,
2001; Rushlow et al., 2001) (Fig. 4A). In the dCBP mutant
embryo shown in Fig. 4B, anti-phospho Smad staining is
reduced, except in an anterior patch of cells, indicating that
reduced tolloid and screw expression indeed impedes Dpp/
Screw signaling. Drosophila Smad proteins are maternally
contributed to the early embryo and consequently present in
all cells. We used an anti-Mad antibody to determine the
amount of Mad protein in dCBP mutant embryos. We ob-
served a slight reduction in staining intensity in dCBP
mutant embryos as compared with wild-type (Fig. 4E and
F). However, we do not believe that this small reduction in
Mad protein levels can account for the reduced phospho-
Smad staining that occurs in only part of the embryo shown
in Fig. 4B. We conclude that phosphorylation of Smad
proteins is impaired in dCBP mutant embryos.
At later stages of development, when embryos are in the
beginning of the germband elongation phase, phosphory-
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lated Smad protein continues to accumulate in dorsal cells
in the wild-type (Fig. 4C). Interestingly, Dpp/Screw signal-
ing recovers in dCBP mutant embryos at this stage, as
revealed by the anti-phospho Smad antibody (Fig. 4D). We
considered the possibility that phospho-Smad staining in
dCBP mutant embryos is caused by the paternal contribu-
tion of dCBP at this later stage of development. To distin-
guish between hemizygous and heterozygous embryos,
males carrying a ftz-lacZ transgene on the FM7c balancer
chromosome were crossed to females containing dCBP
germline clones, and the resulting embryos were double-
stained for lacZ mRNA and phospho-Smad protein. No
difference between embryos that lack or contain lacZ
mRNA was observed (data not shown), indicating that
phospho-Smad staining recovers in the absence of zygoti-
cally produced dCBP. In summary, dCBP inhibits signaling
by Dpp/Screw in early embryos by preventing expression of
the Tolloid protease and Screw itself, whereas in older
embryos, Dpp is able to signal but unable to activate down-
stream target genes such as rhomboid.
Cells receiving the dpp signal require dCBP for target
gene expression
Since not every embryo derived from nej1 germline
clones produces a mutant phenotype, we investigated
whether in the same embryo, Dpp/Screw is able to signal
but unable to turn on gene expression. Embryos were double
stained with a rhomboid probe and the anti-phospho Smad
antibody. For clarity, the expression pattern of rhomboid in
wild-type and mutant embryos is shown in Fig. 5A and B,
respectively. The rhomboid pattern consists of two lateral
stripes that are activated by Dorsal and repressed by the
Snail protein in ventral cells (Ip et al., 1992). In dorsal parts,
rhomboid is independently regulated by Dpp/Screw signal-
Fig. 5. A requirement for dCBP downstream of Smad protein phosphory-
lation. (A, B) Hybridization of a rhomboid (rho) antisense probe to cellu-
larized embryos shown in a ventrolateral view. In wild-type (wt) embryos
(A), the pattern consists of two lateral stripes expressed in response to the
Dorsal protein, and expression in the dorsal ectoderm in response to
Dpp/Screw signaling. In the CBP mutant derived from nej1 germline clones
(B), the lateral stripes are expressed normally, whereas the dorsal staining
is eliminated. (C, D) Gastrulating embryos double-stained with a rho RNA
probe and anti-phospho Smad antibodies. Anterior is to the left and dorsal
up. In the wt embryo shown in (C), the dorsal rho expression partially
overlaps with the phospho-Smad staining, consistent with a requirement for
Dpp/Screw signaling to activate the ectodermal rho expression. However,
the phospho-Smad staining extends further toward the poles than does the
rho pattern. It is likely that spatially localized transcription factors coop-
erate with Smad proteins to activate dorsal rho expression. Rho staining is
also observed in the neuroectoderm, but is weaker at this stage is weaker
than in the embryos shown in (A) and (B). In most CBP germline clone
embryos, neither phosphorylated Smad proteins nor dorsal rho expression
is observed (data not shown). However, in the CBP mutant embryo shown
in (D), dorsal rho staining is not observed, although the cells contain
phosphorylated Smad proteins. This suggests that CBP is required down-
stream of Smad phosphorylation for dorsal rho expression. By contrast, rho
expression in the neuroectoderm is unaffected by the CBP mutation.
Fig. 6. Lowering the dose of dCBP by other means results in similar gene expression defects. Embryos were collected from the stocks of the null allele nej3
or the antimorph nejQ7. Such embryos contain half the amount of maternal dCBP and one-quarter of them lack wild-type zygotic dCBP. The embryos were
hybridized with antisense tolloid (A–C) and rhomboid (D–F) probes. (A–C) Precellular embryos are oriented with anterior to the left and dorsal up. In
wild-type (wt) embryos (A), tolloid is expressed on the dorsal side along the entire anteroposterior axis. Tolloid expression is lost from the middle of embryos
derived from nej3 (B) or nejQ7 (C) heterozygous mothers. (D–F) Cellularized embryos shown from a ventro-lateral view with anterior to the left hybridized
with a rhomboid probe. The wild-type pattern consists of two lateral stripes, as well as dorsal staining in response to Dpp/Screw signaling (D). In embryos
derived from nej3 (E) or nejQ7 (F) heterozygous mothers, the dorsal rhomboid pattern is lost, whereas the lateral stripes are unaffected.
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ing (Ashe et al., 2000). As shown in Fig. 5B, the dorsal,
Dpp/Screw-dependent, rhomboid staining is lost in dCBP
mutants, whereas expression of the two lateral stripes is
unaffected. When wild-type embryos are stained with the
anti-phospho Smad antibody in addition to the rhomboid
probe, the two patterns overlap in dorsal regions, although
the anti-phospo Smad staining extends further toward the
poles than does rhomboid expression (Fig. 5C). Most dCBP
mutant embryos lack phosphorylated Smad proteins, and
consequently do not express rhomboid in dorsal cells (data
not shown). However, in a few late-stage dCBP mutant
embryos, phosphorylated Smad proteins are present in dor-
sal cells, but still no dorsal rhomboid expression is ob-
served, although the two lateral rhomboid stripes are ex-
pressed at normal levels (Fig. 5D). dCBP can therefore act
downstream of Smad phosphorylation to regulate Dpp/
Screw-target genes, presumably via direct interactions with
the Drosophila Smad protein Mad.
Two other dCBP alleles similarly influence the Dpp/Screw
pathway
Since the amount of dCBP is only slightly reduced in
embryos derived from nej1 germline clones as compared
with wild-type (Fig. 1), other means of lowering the dose of
dCBP may also affect the Dpp/Screw pathway. We used
two stronger alleles of dCBP, nej3 that is believed to be a
null allele (Akimaru et al., 1997a), and nejQ7 that is con-
sidered an antimorph (Florence and McGinnis, 1998). Al-
though germline clones cannot be generated with these
alleles, embryos collected from the stocks contain only half
the amount of maternal dCBP. We hybridized these em-
bryos with probes from the tolloid and rhomboid genes,
which shows that similar phenotypes to those observed in
germline clone embryos from the nej1 allele can be found
(Fig. 6). Tolloid expression is restricted to an anterior cap
and to weak posterior staining in nej3 (Fig. 6B) and nejQ7
(Fig. 6C) embryos, compared with staining throughout the
dorsal part of the anteroposterior axis in wild-type embryos
(Fig. 6A). Both nej3 (Fig. 6E) and nejQ7 (Fig. 6F) embryos
lack the dorsal rhomboid pattern that wild-type embryos
express in response to Dpp/Screw signaling (Fig. 6D). Al-
though the phenotype is weaker in nej3 and nejQ7 embryos
than in nej1 germline clone embryos, these results are con-
sistent with our conclusion that genes in the Dpp/Screw
pathway are sensitive to a small decline in dCBP levels.
Discussion
Our results suggest that several transcription factors that
regulate expression of Dpp/Screw signaling components
require the dCBP coactivator for their function in Drosoph-
ila embryos, and implicate dCBP in regulation of the Dpp/
Screw pathway independently of an interaction with Smad
proteins (summarized in Fig. 7). An additional role of dCBP
is to regulate Dpp-target genes, acting at a step downstream
of Smad protein phosphorylation. It is likely that direct
interactions between dCBP and Mad/Medea contribute to
regulation of Dpp target genes (Fig. 7). Such interactions
have been observed in vitro, both in mammalian systems
and using Drosophila proteins (Feng et al., 1998; Janknecht
et al., 1998; Nishihara et al., 1998; Pouponnot et al., 1998;
Topper et al., 1998; Waltzer and Bienz, 1999). However, a
major cause of impaired Dpp/Screw signaling in dCBP
mutant embryos is due to reduced tolloid expression. This
prevents Dpp/Screw from initiating a signaling event in
cells that would normally receive the Dpp/Screw signal
(Fig. 4B), presumably by a failure to cleave the Dpp-Sog
Fig. 7. Summary of the requirements for dCBP in Dpp/Screw signaling. A
cell is depicted as a expressing the screw (scw), tolloid (tld), and twisted-
gastrulation (tsg) genes on the top. dCBP is recruited to the tolloid
enhancer as well as to the tsg and screw genes through interactions with
unidentified factors (proteins X, Y, and Z). Scw, Tld, and Tsg proteins are
secreted from the cell, where Tsg forms a complex with the Sog inhibitor
that can be proteolytically cleaved by Tld. This allows the Dpp and Scw
proteins to bind to their receptors, which leads to phosphorylation of Smad
proteins in the receiving cell (bottom). The phosphorylated Smad protein
Mad dimerizes with its partner Medea, and translocates to nucleus, where
it turns on gene expression. dCBP is required downstream of Smad protein
phosphorylation, presumably acting as a Mad coactivator on the rhomboid
dorsal ectoderm enhancer.
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and/or Screw-Sog complexes. In fact, a majority of embryos
that do not express the Dpp/Screw-target gene rhomboid in
dorsal cells, also do not contain phosphorylated Smad pro-
teins (data not shown). Furthermore, the pattern of phos-
phorylated Smad proteins correlates closely to that of tolloid
expression (compare Figs. 3 and 4). For example, in many
early, cellularizing dCBP mutant embryos, an anterior patch
of both tolloid expression and phosphorylated Smad stain-
ing remains (Figs. 3B and 4B). At later stages, tolloid
expression recovers in dCBP mutant embryos, as does Dpp/
Screw signaling as revealed by Smad protein phosphoryla-
tion (Figs. 3D and 4D). This recovery of tolloid expression
at later stages of development might explain the recovery of
phosphorylated Smad proteins in dCBP mutant embryos, by
allowing Dpp/Screw to signal. For these reasons, regulation
of tolloid expression appears to be a major means of con-
trolling Dpp/Screw signaling by dCBP.
It is likely that reduced screw expression also contributes
to the reduction of phosphorylated Smad proteins observed
in dCBP mutant embryos. In both screw and tolloid mu-
tants, phosphorylation of Mad is eliminated (Dorfman and
Shilo, 2001) and dorsal rhomboid expression is abolished
(Marques et al., 1997; Nguyen et al., 1998). Furthermore,
progressive reduction in Screw activity leads to a corre-
sponding progressive deletion of dorsal-most cell fate, the
amnioserosa (Arora et al., 1994).
Tsg is required together with Sog to generate peak Dpp
activity in dorsal midline cells. Reduced tsg expression in
dCBP mutants may therefore contribute to the lack of Dpp/
Screw-target gene expression. However, we do not believe
that it can explain the defects in dCBP mutants, because in
tsg mutants, low levels of Dpp signaling persist in a broad
dorsal domain, leading to expanded rhomboid expression in
dorsal cells (Ross et al., 2001). By contrast, in dCBP mutant
embryos, expression of genes in response to a low threshold
of Dpp activity, such as U-shaped and the dorsal rhomboid
pattern, is eliminated (Ashe et al., 2000; see also Fig. 5).
Our experiments do not address whether dCBP regula-
tion of tolloid, screw, and tsg expression is direct or indirect.
However, since expression of these genes begins at about
the time when zygotic transcription initiates in the embryo,
and the effect of dCBP is evident from the onset of expres-
sion of tolloid and screw, we favor the notion that dCBP is
acting directly on the enhancers of these genes. It is not yet
understood whether HATs such as CBP primarily act to
acetylate large chromosomal domains, or are directed to
specific genes (Roth et al., 2001). In the case of the tolloid
gene, our results indicate that dCBP is being recruited to the
enhancer by a DNA-binding protein, since the isolated en-
hancer removed from its normal chromosomal location re-
quires dCBP for its activity.
Given its central position in gene regulation and the great
number of mammalian transcription factors shown to inter-
act with CBP, relatively few genes are affected by the dCBP
mutation. For example, activation and repression mediated
by the Dorsal protein are unaffected in the dCBP mutant
embryos, as demonstrated by the expression patterns of
Dorsal target genes (Figs. 2 and 5; and data not shown).
Also, no defects in early segmentation gene expression
could be observed in germline clone mutants (data not
shown). However, the nej1 mutation used in this study to
create dCBP mutant germline clone embryos is a weak
mutation that results in a very modest reduction in dCBP
levels (Fig. 1). Since other means of reducing the dCBP
amount by approximately two-fold results in similar gene
expression defects (Fig. 6), Smad proteins and the uniden-
tified activators of tolloid, tsg, and screw expression are
particularly sensitive to a decline in dCBP concentration. It
may not be a coincidence that screw, tsg, tolloid, and Dpp-
target gene expression are all specifically affected by a
small dCBP reduction. Perhaps components of the Dpp/
Screw signal transduction pathway have evolved to be co-
ordinately regulated by a common coactivator. Given the
phylogenetic conservation of the CBP protein and the
TGF- signal transduction pathway, as well as the ability of
CBP and Smad proteins to interact in vitro, CBP is likely to
play an equally important role in TGF- signaling in other
metazoans.
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